Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial.
Selvanayagam JB, Hartshorne T, Billot L, Grover S, Hillis GS, Jung W, Krum H, Prasad S, McGavigan AD. Selvanayagam JB, et al. Among authors: billot l. Ann Noninvasive Electrocardiol. 2017 Jul;22(4):e12420. doi: 10.1111/anec.12420. Epub 2017 Jan 24. Ann Noninvasive Electrocardiol. 2017. PMID: 28117536 Free PMC article. Clinical Trial.
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
Patel A, Cass A, Peiris D, Usherwood T, Brown A, Jan S, Neal B, Hillis GS, Rafter N, Tonkin A, Webster R, Billot L, Bompoint S, Burch C, Burke H, Hayman N, Molanus B, Reid CM, Shiel L, Togni S, Rodgers A; Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. Patel A, et al. Among authors: billot l. Eur J Prev Cardiol. 2015 Jul;22(7):920-30. doi: 10.1177/2047487314530382. Epub 2014 Mar 27. Eur J Prev Cardiol. 2015. PMID: 24676715 Clinical Trial.
Statistical analysis plan for the Sleep Apnea cardioVascular Endpoints study: An international randomised controlled trial to determine whether continuous positive airways pressure treatment for obstructive sleep apnea in patients with CV disease prevents secondary cardiovascular events.
Heeley E, Billot L, Anderson CS, Antic NA, Neal B, McEvoy RD; SAVE investigators. Heeley E, et al. Among authors: billot l. Int J Stroke. 2016 Jan;11(1):148-50. doi: 10.1177/1747493015607504. Int J Stroke. 2016. PMID: 26763030 Clinical Trial.
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease.
Angell B, Laba TL, Lung T, Brown A, Eades S, Usherwood T, Peiris D, Billot L, Hillis G, Webster R, Tonkin A, Reid C, Molanus B, Rafter N, Cass A, Patel A, Jan S. Angell B, et al. Among authors: billot l. Int J Equity Health. 2017 Jun 23;16(1):108. doi: 10.1186/s12939-017-0610-2. Int J Equity Health. 2017. PMID: 28645284 Free PMC article. Clinical Trial.
TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
Chow CK, Thiagalingam A, Santo K, Kok C, Thakkar J, Stepien S, Billot L, Jan S, Joshi R, Hillis GS, Brieger D, Chew DP, Rådholm K, Atherton JJ, Bhindi R, Collins N, Coverdale S, Hamilton-Craig C, Kangaharan N, Maiorana A, McGrady M, Shetty P, Thompson P, Rogers A, Redfern J. Chow CK, et al. Among authors: billot l. BMJ Open. 2018 Jan 27;8(1):e019463. doi: 10.1136/bmjopen-2017-019463. BMJ Open. 2018. PMID: 29374674 Free PMC article. Clinical Trial.
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.
Chow CK, Atkins ER, Billot L, Chalmers J, Hillis GS, Hay P, Neal B, Nelson M, Patel A, Reid CM, Schlaich M, Usherwood T, Webster R, Rodgers A. Chow CK, et al. Among authors: billot l. Am Heart J. 2021 Jan;231:56-67. doi: 10.1016/j.ahj.2020.09.017. Epub 2020 Oct 2. Am Heart J. 2021. PMID: 33017580 Free PMC article.
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
Chow CK, Atkins ER, Hillis GS, Nelson MR, Reid CM, Schlaich MP, Hay P, Rogers K, Billot L, Burke M, Chalmers J, Neal B, Patel A, Usherwood T, Webster R, Rodgers A; QUARTET Investigators. Chow CK, et al. Among authors: billot l. Lancet. 2021 Sep 18;398(10305):1043-1052. doi: 10.1016/S0140-6736(21)01922-X. Epub 2021 Aug 29. Lancet. 2021. PMID: 34469767 Clinical Trial.
Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET Study.
Nolde JM, Atkins E, Marschner S, Hillis GS, Chalmers J, Billot L, Nelson MR, Reid CM, Hay P, Burke M, Jansen S, Usherwood T, Rodgers A, Chow CK, Schlaich MP. Nolde JM, et al. Among authors: billot l. Circulation. 2023 Jul 25;148(4):375-377. doi: 10.1161/CIRCULATIONAHA.123.064964. Epub 2023 Jul 24. Circulation. 2023. PMID: 37486996 No abstract available.
Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure.
Atkins ER, Chye A, Lung T, Nolde JM, Billot L, Burke M, Chalmers J, Figtree GA, Hay P, Hillis GS, Jansen S, Marschner S, Neal B, Nelson MR, Reid CM, Usherwood T, Schlaich M, Chow CK, Rodgers A. Atkins ER, et al. Among authors: billot l. Heart. 2023 Oct 26;109(22):1698-1705. doi: 10.1136/heartjnl-2022-322300. Heart. 2023. PMID: 37553138
Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET Trial.
Wang N, Von Huben A, Marschner S, Nelson MR, Nolde JM, Schlaich MP, Figtree G, Hillis GS, Usherwood T, Reid CM, Chalmers J, Jansen S, Atkins ER, Billot L, Chow C, Rodgers A; QUARTET Investigators. Wang N, et al. Among authors: billot l. Hypertension. 2024 May;81(5):1087-1094. doi: 10.1161/HYPERTENSIONAHA.123.22284. Epub 2024 Mar 13. Hypertension. 2024. PMID: 38477128 Clinical Trial.
207 results